Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 759, Issue , 2014, Pages 16-21

  Tong, Na ^a,b   Xu, Bin ^c   Shi, Danni ^a,b   Du, Mulong ^a,b   Li, Xin ^a,b   Sheng, Xiaojing ^a,b   Wang, Meilin ^a,b   Chu, Haiyan ^a,b   Fang, Yongjun ^d   Li, Jie ^e   Wu, Dongmei ^a,b   Zhang, Zhengdong ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c SOUTHEAST UNIVERSITY   (China)

^d CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Childhood ALL; Genetic susceptibility; Hsa miR 196a2; Molecular epidemiology

Indexed keywords

HOMEODOMAIN PROTEIN; MICRORNA; MICRORNA 196A2; PROTEIN HOXC8; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BIOINFORMATICS; CANCER RISK; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; WILD TYPE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALL; CHILDHOOD ALL; CIS; CONFIDENCE INTERVALS; GENETIC SUSCEPTIBILITY; HSA-MIR-196A2; MOLECULAR EPIDEMIOLOGY; ODDS RATIOS; OR; SINGLE NUCLEOTIDE POLYMORPHISM; SNP;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK;

EID: 84891658829     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2013.11.004     Document Type: Article

References (40)

1. Belson M., Kingsley B., Holmes A. Risk factors for acute leukemia in children: a review. Environ. Health Perspect. 2007, 115:138-145.
2. Saunders M.A., Liang H., Li W.H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3300-3305.
3. Schmittgen T.D., Jiang J., Liu Q., Yang L. A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004, 32:e43.
4. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
5. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
6. Hoffman A.E., Zheng T., Yi C., Leaderer D., Weidhaas J., Slack F., Zhang Y., Paranjape T., Zhu Y. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009, 69:5970-5977.
7. Xu W., Xu J., Liu S., Chen B., Wang X., Li Y., Qian Y., Zhao W., Wu J. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS ONE 2011, 6:e20471.
8. Tian T., Xu Y., Dai J., Wu J., Shen H., Hu Z. Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int. J. Mol. Epidemiol. Genet. 2010, 1:358-366.
9. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., Zeng Y., Miao R., Jin G., Ma H., Chen Y., Shen H. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 2008, 118:2600-2608.
10. Okubo M., Tahara T., Shibata T., Yamashita H., Nakamura M., Yoshioka D., Yonemura J., Ishizuka T., Arisawa T., Hirata I. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010, 15:524-531.
11. Zhu L., Chu H., Gu D., Ma L., Shi D., Zhong D., Tong N., Zhang Z., Wang M. A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol. 2012, 31:350-354.
12. Kim M.J., Yoo S.S., Choi Y.Y., Park J.Y. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 2010, 69:127-129.
13. George G.P., Gangwar R., Mandal R.K., Sankhwar S.N., Mittal R.D. Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol. Biol. Rep. 2011, 38:1609-1615.
14. Tong N., Fang Y., Li J., Wang M., Lu Q., Wang S., Tian Y., Rong L., Sun J., Xu J., Zhang Z. Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci. 2010, 101:782-786.
15. Sheng X., Tong N., Tao G., Luo D., Wang M., Fang Y., Li J., Xu M., Zhang Z., Wu D. TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children. Carcinogenesis 2013, 34:228-235.
16. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
17. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
18. Kumar M.S., Lu J., Mercer K.L., Golub T.R., Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 2007, 39:673-677.
19. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., Shen H. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 2009, 30:79-84.
20. Catucci I., Yang R., Verderio P., Pizzamiglio S., Heesen L., Hemminki K., Sutter C., Wappenschmidt B., Dick M., Arnold N., Bugert P., Niederacher D., Meindl A., Schmutzler R.K., Bartram C.C., Ficarazzi F., Tizzoni L., Zaffaroni D., Manoukian S., Barile M., Pierotti M.A., Radice P., Burwinkel B., Peterlongo P. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 2010, 31:E1052-E1057.
21. Linhares J.J., Azevedo M., Siufi A.A., de Carvalho C.V., Wolgien Mdel C., Noronha E.C., Bonetti T.C., da Silva I.D. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913C/T) from Brazilian women with breast cancer. BMC Med. Genet. 2012, 13:119.
22. Qi P., Dou T.H., Geng L., Zhou F.G., Gu X., Wang H., Gao C.F. Association of a variant in MIR 196a2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum. Immunol. 2010, 71:621-626.
23. Hezova R., Kovarikova A., Bienertova-Vasku J., Sachlova M., Redova M., Vasku A., Svoboda M., Radova L., Kiss I., Vyzula R., Slaby O. Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J. Gastroenterol. 2012, 18:2827-2831.
24. Srivastava K., Srivastava A. Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS ONE 2012, 7:e50966.
25. Chu H., Wang M., Shi D., Ma L., Zhang Z., Tong N., Huo X., Wang W., Luo D., Gao Y. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS ONE 2011, 6:e18108.
26. Yang J.J., Cheng C., Yang W., Pei D., Cao X., Fan Y., Pounds S.B., Neale G., Trevino L.R., French D., Campana D., Downing J.R., Evans W.E., Pui C.H., Devidas M., Bowman W.P., Camitta B.M., Willman C.L., Davies S.M., Borowitz M.J., Carroll W.L., Hunger S.P., Relling M.V. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. J Am Med Assoc 2009, 301:393-403.
27. Papaemmanuil E., Hosking F.J., Vijayakrishnan J., Price A., Olver B., Sheridan E., Kinsey S.E., Lightfoot T., Roman E., Irving J.A., Allan J.M., Tomlinson I.P., Taylor M., Greaves M., Houlston R.S. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009, 41:1006-1010.
28. Trevino L.R., Yang W., French D., Hunger S.P., Carroll W.L., Devidas M., Willman C., Neale G., Downing J., Raimondi S.C., Pui C.H., Evans W.E., Relling M.V. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet. 2009, 41:1001-1005.
29. Sherborne A.L., Hosking F.J., Prasad R.B., Kumar R., Koehler R., Vijayakrishnan J., Papaemmanuil E., Bartram C.R., Stanulla M., Schrappe M., Gast A., Dobbins S.E., Ma Y., Sheridan E., Taylor M., Kinsey S.E., Lightfoot T., Roman E., Irving J.A., Allan J.M., Moorman A.V., Harrison C.J., Tomlinson I.P., Richards S., Zimmermann M., Szalai C., Semsei A.F., Erdelyi D.J., Krajinovic M., Sinnett D., Healy J., Gonzalez Neira A., Kawamata N., Ogawa S., Koeffler H.P., Hemminki K., Greaves M., Houlston R.S. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010, 42:492-494.
30. Ellinghaus E., Stanulla M., Richter G., Ellinghaus D., te Kronnie G., Cario G., Cazzaniga G., Horstmann M., Panzer Grumayer R., Cave H., Trka J., Cinek O., Teigler-Schlegel A., ElSharawy A., Hasler R., Nebel A., Meissner B., Bartram T., Lescai F., Franceschi C., Giordan M., Nurnberg P., Heinzow B., Zimmermann M., Schreiber S., Schrappe M., Franke A. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 2012, 26:902-909.
31. Han S., Lee K.M., Park S.K., Lee J.E., Ahn H.S., Shin H.Y., Kang H.J., Koo H.H., Seo J.J., Choi J.E., Ahn Y.O., Kang D. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk. Res. 2010, 34:1271-1274.
32. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
33. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
34. Xu J., Hu Z., Xu Z., Gu H., Yi L., Cao H., Chen J., Tian T., Liang J., Lin Y., Qiu W., Ma H., Shen H., Chen Y. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum. Mutat. 2009, 30:1231-1236.
35. Boucherat O., Guillou F., Aubin J., Jeannotte L. Hoxa5: a master gene with multifaceted roles. Med. Sci. (Paris) 2009, 25:77-82.
36. Li Y., Zhang M., Chen H., Dong Z., Ganapathy V., Thangaraju M., Huang S. Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res. 2010, 70:7894-7904.
37. Bertrand F.E., Spengeman J.D., Shah N., LeBien T.W. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression. Leukemia 2003, 17:2454-2459.
38. Ferrando A.A., Armstrong S.A., Neuberg D.S., Sallan S.E., Silverman L.B., Korsmeyer S.J., Look A.T. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003, 102:262-268.
39. Magli M.C., Largman C., Lawrence H.J. Effects of HOX homeobox genes in blood cell differentiation. J. Cell. Physiol. 1997, 173:168-177.
40. Cillo C., Cantile M., Faiella A., Boncinelli E. Homeobox genes in normal and malignant cells. J. Cell. Physiol. 2001, 188:161-169.